期刊文献+

小檗碱对高脂饲料所致大鼠非酒精性脂肪肝的保护作用 被引量:4

Protective Effect of Berberine on the Nonalcoholic Fatty Liver Induced by High-Fat Diet in Rats
原文传递
导出
摘要 目的:观察小檗碱对高脂饲料所致非酒精性脂肪肝的影响。方法:采用高脂饲料建立大鼠脂肪肝模型,治疗组分别灌胃给予小檗碱100和200 mg/kg。4周后,处死动物,检测肝指数、抗氧化功能、血清及肝脏中脂质含量等指标。结果:小檗碱能改善大鼠肝指数,明显降低血清及肝匀浆中甘油三酯含量,下调血清游离脂肪酸含量,提高肝匀浆超氧化物岐化酶活性。结论:小檗碱对高脂饲料所致大鼠非酒精性脂肪肝具有一定的保护作用,其机制与调节血脂、提高肝脏抗氧化能力有关。 Objective: To observe the protective effects of berberine on nonalcoholic fatty liver induced by high-fat diet in rats. Methods: Fatty liver disease model was established by feeding rats with high-fat diet. The therapeutic groups were administered with berberine by gavage at the dose of 100 and 200 mg/kg daily. After four weeks, all rats were sacrificed. Liver index, anti-oxidative function, blood and liver lipid were assayed. Results: Berberine decreased the liver index, re duced the content of serum and hepatic triglycerides, lowered the serum free fatty acid level, and increased liver homogenate SOD activity of rats with fatty liver. Conclusion: Bererine can protect rats from nonalcoholic fatty liver disease induced by high-fat diet maybe through lowering blood lipid level and improving hepatic anti-oxidative capability.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2010年第1期65-67,91,共4页 Medical Journal of Wuhan University
关键词 小檗碱 非酒精性脂肪肝 脂质过氧化 Berberine Nonalcoholic Fatty Liver Disease Lipid Peroxidation
  • 相关文献

参考文献6

二级参考文献117

  • 1病毒性肝炎防治方案(试行)[J].中西医结合肝病杂志,1996,6(1):50-53. 被引量:136
  • 2张蓉,刘宇,刘秉文.血浆脂蛋白脂酶及肝脂酶的比色测定法[J].华西医科大学学报,1996,27(1):106-110. 被引量:34
  • 3[9]Uesugi T, Froh M, Arteel GE, Bradford BU, Wheeler MD, Gabele E, Isayama F, Thurman RG. Role of lipopolysaccharidebinding protein in early alcohol-induced liver injury in mice. J Immunol2002; 168:2963-2969
  • 4[10]Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999; 276: R136-R142
  • 5[11]Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003; 37:343-350
  • 6[12]Hug H, Strand S, Grambihler A, Galle J, Hack V, Stremmel W,Krammer PH, Galle PR. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 1997; 272:28191-28193
  • 7[13]Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.Gastroenterology 2003; 125:437-443
  • 8[14]American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology 2002; 123:1702-1704
  • 9[15]Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects.J Hepatol1991; 12:224-229
  • 10[16]Luyckx FH, Scheen AJ, Desaive C, Dewe W, Gielen JE, Lefebvre PJ. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab 1998;24:355-361

共引文献151

同被引文献96

引证文献4

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部